Relief therapeutics and acer therapeutics sign option agreement for exclusivity to negotiate a collaboration and license agreement for the worldwide development and commercialization of acer-001 for the treatment of urea cycle disorders and maple syrup urine disease

Acer to receive $1 million payment to obtain exclusivity and a $4 million loan from relief
ACER Ratings Summary
ACER Quant Ranking